These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6869315)

  • 21. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
    Mannel RS; Blessing JA; Boike G
    Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced or metastatic squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.
    McGuire WP; Blessing JA; Yordan E; Beecham J
    Invest New Drugs; 1989 Jul; 7(2-3):235-8. PubMed ID: 2793379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II trial of tricyclic nucleoside phosphate in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
    Feun LG; Blessing JA; Barrett RJ; Hanjani P
    Am J Clin Oncol; 1993 Dec; 16(6):506-8. PubMed ID: 8256767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of a phase II study of maytansine in patients with breast carcinoma and melanoma.
    Cabanillas F; Bodey GP; Burgess MA; Freireich EJ
    Cancer Treat Rep; 1979 Mar; 63(3):507-9. PubMed ID: 371803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix.
    Morris M; Brader KR; Levenback C; Burke TW; Atkinson EN; Scott WR; Gershenson DM
    J Clin Oncol; 1998 Mar; 16(3):1094-8. PubMed ID: 9508195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II trials of maytansine, low-dose chlorozotocin, and high-dose chlorozotocin as single agents against advanced measurable adenocarcinoma of the pancreas. Gastrointestinal Tumor Study Group.
    Cancer Treat Rep; 1985 Apr; 69(4):417-20. PubMed ID: 2859924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix.
    Irvin WP; Price FV; Bailey H; Gelder M; Rosenbluth R; Durivage HJ; Potkul RK
    Cancer; 1998 Jan; 82(2):328-33. PubMed ID: 9445190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trials of cisplatin and piperazinedione as single agents in the treatment of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Thigpen JT; Blessing JA; Fowler WC; Hatch K
    Cancer Treat Rep; 1986 Sep; 70(9):1097-100. PubMed ID: 3755650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized phase II trial of trimetrexate or didemnin B for the treatment of metastatic or recurrent squamous carcinoma of the uterine cervix: a Southwest Oncology Group trial.
    Weiss GR; Liu PY; O'Sullivan J; Alberts DS; Brown TD; Neefe JR; Hutchins LF
    Gynecol Oncol; 1992 Jun; 45(3):303-6. PubMed ID: 1535329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cis-platinum in the treatment of advanced or recurrent adenocarcinoma of the ovary. A phase II study of the Gynecologic Oncology Group.
    Thigpen JT; Lagasse L; Homesley H; Blessing JA
    Am J Clin Oncol; 1983 Aug; 6(4):431-5. PubMed ID: 6683465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II evaluation of maytansine (NSC 153858) in advanced cancer. A Southeastern Cancer Study Group trial.
    Ravry MJ; Omura GA; Birch R
    Am J Clin Oncol; 1985 Apr; 8(2):148-50. PubMed ID: 3834790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II trial of didemnin B (NSC #335319) in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
    Malfetano JH; Blessing JA; Homesley HD; Look KY; McGehee R
    Am J Clin Oncol; 1996 Apr; 19(2):184-6. PubMed ID: 8610646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of vinblastine in previously treated squamous carcinoma of the cervix. A Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Barnes W; Ball H
    Am J Clin Oncol; 1990 Dec; 13(6):470-1. PubMed ID: 2239800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-fluorouracil and low-dose leucovorin in the treatment of recurrent squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Look KY; Blessing JA; Muss HB; Partridge EE; Malfetano JH
    Am J Clin Oncol; 1992 Dec; 15(6):497-9. PubMed ID: 1449112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; McGuire WP; Patton T; Look KY
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):805-7. PubMed ID: 8456884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group study.
    Slayton RE; Blessing JA; Rettenmaier M; Ball H
    Invest New Drugs; 1989 Nov; 7(4):337-40. PubMed ID: 2599803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PALA (NSC-224131) in advanced carcinoma of the cervix. A phase II study of the Gynecologic Oncology Group.
    Muss HB; Bundy B; DiSaia PJ; Stehman FB; Beecham J
    Am J Clin Oncol; 1984 Dec; 7(6):741-4. PubMed ID: 6528869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study).
    Arseneau J; Blessing JA; Stehman FB; McGehee R
    Invest New Drugs; 1986; 4(2):187-91. PubMed ID: 3525449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II evaluation of mitolactol in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Stehman FB; Blessing JA; McGehee R; Barrett RJ
    J Clin Oncol; 1989 Dec; 7(12):1892-5. PubMed ID: 2685182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Rose PG; Blessing JA; Arseneau J
    Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.